verified SJR 0,927 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Taylor and Francis Ltd.

workspace_premium Q1 — Health Policy lock Subscription

Journal of Medical Economics

Journal of Medical Economics is a journal indexed in SJR in Health Policy with an H index of 58. It has a price of 4000 €. It has an SJR impact factor of 0,927 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,927.

Journal of Medical Economics focuses its scope in these topics and keywords: patients, burden, diabetes, insulin, united, study, costs, european, comparison, highcost, ...

ISSN: 1369-6998

Publisher: Taylor and Francis Ltd.

Category: Health Policy

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,927 Q1

H-index 58

Acceptance rate pie_chart

31%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

4.000 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,927

H-index

Docs (year)

179

Docs 3y

456

Total refs

6735

Cites 3y

1232

Citable 3y

420

Cites/Doc 2y

2.67

Ref/Doc

37.63

Immediate OA

4000 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Burden of blood transfusion in knee and hip surgery in the US and Belgium

Workplace productivity, employment issues, and resource utilization in patients with bipolar I disorder

Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients

Cost-effectiveness analysis of mechanical thrombectomy with stent retriever in the treatment of acute ischemic stroke in Italy

Cost utility of palivizumab prophylaxis among pre-term infants in the United States: a national policy perspective

Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis

Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare system

Cost analysis of leuprorelin acetate in Japanese prostate cancer patients: comparison between 6-month and 3-month depot formulations

Corroboration of claims algorithm for second-line costs of metastatic colorectal cancer treatment with targeted agents

Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy

Clinical and economic burden of chemotherapy-induced nausea and vomiting among patients with cancer in a hospital outpatient setting in the United States

Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada

SHOW MORE ARTICLES

Changing costs and the impact on RSV prophylaxis

A best-worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment

Budget impact model of tobramycin inhalation solution for treatment ofPseudomonas aeruginosain cystic fibrosis patients

Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer in Kazakhstan

Application of a simple point-of-care test to reduce UK healthcare costs and adverse events in outpatient acute respiratory infections

Annual patient and caregiver burden of oncology clinic visits for granulocyte-colony stimulating factor therapy in the US

An assessment of the cost of percutaneous pulmonary valve implantation (PPVI) versus surgical pulmonary valve replacement (PVR) in patients with right ventricular outflow tract dysfunction

An analysis of clinical outcomes and costs of a long term acute care hospital

Adherence to guidelines for sensitivity analysis: cost-effectiveness analyses of dual oral antiplatelet therapy

A discrete choice experiment to assess patients' preferences for HIV treatment in the urban population in Colombia

A critical review of the full economic evaluations of pharmacological treatments for glaucoma

A cost comparison of long-acting insulin analogs vs NPH insulin-based treatment in patients with type 2 diabetes using routinely collected primary care data from the UK

FAQs

Journal of Medical Economics has an SJR of 0,927 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 4000 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Journal of Medical Economics is 31%.

Journal of Medical Economics

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Medical Economics?

What is the APC / publication cost?

What is the acceptance rate?